CAPR CAPRICOR THERAPEUTICS INC
2026Q1 · CUSIP 14070B309 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
176
Δ holders QoQ
+44
Breadth percentile
Top 5%
Whale holders
96
Δ whales
+26
Inst. holding value
$1.0B
New positions
71
Closed positions
27
Price momentum (1Q)
+21.7%
Put / Call
6/13
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 5% | — | — |
| 2025Q1 | Top 18% | -26.0% | -45.1% |
| 2024Q4 | Top 16% | -30.5% | -48.6% |
| 2024Q1 | Top 15% | — | — |
Options Sentiment
Put holders
6
QoQ: -2
Call holders
13
QoQ: +3
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.32
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-41.1%
Debt ratio
14.6%
FCF (TTM)
-$100M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.